14-3-3 tau (YWHAQ) gene promoter hypermethylation in human placenta of preeclampsia

Placenta

Volumn 35, Issue 12, 2014, Pages 981-988

  Liu, H ^a   Tang, Y ^a   Liu, X ^a   Zhou, Q ^a   Xiao, X ^a   Lan, F ^a   Li, X ^a   Hu, R ^a   Xiong, Y ^a   Peng, T ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

14 3 3 tau; 5 hmC; Methylation; Placenta; Preeclampsia; TETs

Indexed keywords

14 3 3 TAU PROTEIN; BISULFITE; GENOMIC DNA; TAU PROTEIN; UNCLASSIFIED DRUG; PROTEIN 14 3 3;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; DNA METHYLATION; FEMALE; GENE DISRUPTION; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PLACENTA; PREECLAMPSIA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; DOWN REGULATION; GENETICS; METABOLISM; PATHOLOGY; PREGNANCY; UPREGULATION;

14-3-3 PROTEINS; ADULT; DNA METHYLATION; DOWN-REGULATION; FEMALE; HUMANS; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; PROMOTER REGIONS, GENETIC; UP-REGULATION;

EID: 84922398182     PISSN: 01434004     EISSN: 15323102     Source Type: Journal    
DOI: 10.1016/j.placenta.2014.09.016     Document Type: Article

References (44)

1. Roberts JM, Cooper DW. Pathogenesis and genetics of pre-eclampsia. Lancet 2001;357:53-6.
2. Uzan J, Carbonnel M, Piconne O, Asmar R, Ayoubi JM. Pre-eclampsia: pathophysiology, diagnosis, and management. Vasc Health Risk Manag 2011;7: 467-74.
3. Young BC, Levine RJ, Karumanchi SA. Pathogenesis of preeclampsia. Annu Rev Pathol 2010;5:173-92.
4. McMaster MT, Zhou Y, Fisher SJ. Abnormal placentation and the syndrome of preeclampsia. Semin Nephrol 2004;24:540-7.
5. Hu R, Jin H, Zhou S, Yang P, Li X. Proteomic analysis of hypoxia-induced responses in the syncytialization of human placental cell line BeWo. Placenta 2007;28:399-407.
6. Cheng Y, Hu R, Jin H, Ma K, Zhou S, Cheng H, et al. Effect of 14-3-3 tau protein on differentiation in BeWo choriocarcinoma cells. Placenta 2010;31:60-6.
7. Leffers H, Madsen P, Rasmussen HH, Honore B, Andersen AH, Walbum E, et al. Molecular cloning and expression of the transformation sensitive epithelial marker stratifin. A member of a protein family that has been involved in the protein kinase C signalling pathway. J Mol Biol 1993;231:982-98.
8. Hoang VM, Foulk R, Clauser K, Burlingame A, Gibson BW, Fisher SJ. Functional proteomics: examining the effects of hypoxia on the cytotrophoblast protein repertoire. Biochemistry 2001;40:4077-86.
9. Park JK, Kang MY, Kim YH, Jo HC, Shin JK, Choi WJ, et al. PKC delta in preeclamptic placentas promotes Bax dissociation from 14-3-3 zeta through 14-3-3 zeta phosphorylation. Placenta 2008;29:584-92.
10. Chelbi ST, Vaiman D. Genetic and epigenetic factors contribute to the onset of preeclampsia. Mol Cell Endocrinol 2008;282:120-9.
11. Gascoin-Lachambre G, Buffat C, Rebourcet R, Chelbi ST, Rigourd V, Mondon F, et al. Cullins in human intrauterine growth restriction: expressional and epigenetic alterations. Placenta 2010;31:151-7.
12. Bellido ML, Radpour R, Lapaire O, Bie ID, Hösli I, Bitzer J, et al. MALDI-TOF massarray analysis of RASSF1A and SERPINB5 methylation patterns in human placenta and plasma. Biol Reprod 2010;82:745-50.
13. Bergman Y, Cedar H. DNA methylation dynamics in health and disease. Nat Struct Mol Biol 2013;20:274-81.
14. Haffner MC, Chaux A, Meeker AK, Esopi DM, Gerber J, Pellakuru LG, et al. Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers. Oncotarget 2011;2:627-37.
15. Jin SG, Jiang Y, Qiu R, Rauch TA, Wang Y, Schackert G, et al. 5-Hydroxymethylcytosine is strongly depleted in human cancers but its levels do not correlate with IDH1 mutations. Cancer Res 2011;71:7360-5.
16. Kraus TF, Globisch D, Wagner M, Eigenbrod S, Widmann D, Munzel M, et al. Low values of 5-hydroxymethylcytosine (5hmC), the "sixth base", are associated with anaplasia in human brain tumors. Int J Cancer 2012;131:1577-80.
17. Kudo Y, Tateishi K, Yamamoto K, Yamamoto S, Asaoka Y, Ijichi H, et al. Loss of 5-hydroxymethylcytosine is accompanied with malignant cellular transformation. Cancer Sci 2012;103:670-6.
18. Yang H, Liu Y, Bai F, Zhang JY, Ma SH, Liu J, et al. Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation. Oncogene 2013;32:663-9.
19. Koh KP, Yabuuchi A, Rao S, Huang Y, Cunniff K, Nardone J, et al. Tet1 and Tet2 regulate 5-hydroxymethylcytosine production and cell lineage specification in mouse embryonic stem cells. Cell Stem Cell 2011;8:200-3.
20. Nishizawa H, Ota S, Suzuki M, Kato T, Sekiya T, Kurahashi H, et al. Comparative gene expression profiling of placentas from patients with severe preeclampsia and unexplained fetal growth restriction. Reprod Biol Endocrinol 2011;9:107-18.
21. Mayor-Lynn K, Toloubeydokhti T, Cruz AC, Chegini N. Expression profile of MicroRNAs and mRNAs in human placentas from pregnancies complicated by preeclampsia and preterm labor. Reprod Sci 2011;18:46-56.
22. Junus K, Centlow M, Wikstrom A-K, Larsson I, Hansson SR, Olovsson M. Gene expression profiling of placentae from women with early- and late-onset preeclampsia: down-regulation of the angiogenesis-related genes ACVRL1 and EGFL7 in early-onset disease. MHR 2012;12:146-55.
23. Xu Y, Wu F, Tan L, Kong L, Xiong L, Deng J, et al. Genome-wide regulation of 5hmC, 5mC, and gene expression by Tet1 hydroxylase in mouse embryonic stem cells. Mol Cell 2011;42:451-64.
24. Blair JD, Yuen RK, Lim BK, McFadden DE, von Dadelszen P, Robinson WP. Widespread DNA hypomethylation at gene enhancer regions in placentas associated with early-onset pre-eclampsia. MHR 2013;19:697-708.
25. Shim V, Gauthier ML, Sudilovsky D, Mantei K, Chew KL, Moore DH, et al. Cyclooxygenase-2 expression is related to nuclear grade in ductal carcinoma in situ and is increased in its normal adjacent epithelium. Cancer Res 2003;63: 2347-50.
26. Lee SA, Ding C. The dysfunctional placenta epigenome: causes and consequences. Epigenomics 2012;4:561-9.
27. Corrie MW, Kate T, Abigail F. Gestational weight gain as a risk factor for hypertensive disorders of pregnancy. Am J Obstet Gynecol 2013;209. 327.e1-e17.
28. Inmaculada BC, Patricia HS, Nestor AP, Jose GS, Alicia GQ, Jose GH, et al. Maternal obesity in early pregnancy and risk of adverse outcomes. PLOS ONE 2013;8:e80410.
29. Bin L, Yun X, Courtney V, Qiu FH, Zhao MZ, Liu YD, et al. Altered protein expression in gestational diabetes mellitus placentas provides insight into insulin resistance and coagulation/fibrinolysis pathway. PLOS ONE 2012;7: e44701.
30. Hoegh AM, Borup R, Nielsen FC, Sørensen S, Hviid TVF. Gene expression profiling of placentas affected by pre-eclampsia. J Biomed Biotechnol 2010;2010:1-11.
31. Alexandre-Gouabau Marie-Cecile F, Bailly E, Moyon TL. Postnatal growth velocity modulates alterations of proteins involved in metabolism and neuronal plasticity in neonatal hypothalamus in rats born with intrauterine growth restriction. J Nutr Biochem 2012;23:140-52.
32. Rosenquist M. 14-3-3 proteins in apoptosis. Braz J Med Biol Res 2003;36: 403-8.
33. Papageorgiou EA, Fiegler H, Rakyan V, Rakyan V, Beck S, Hulten M, et al. Sites of differential DNA methylation between placenta and peripheral blood: molecular markers for noninvasive prenatal diagnosis of aneuploidies. Am J Pathol 2009;174:1609-18.
34. Radhakrishnan VM, Jensen TJ, Cui HY. Hypomethylation of the 14-3-3σ promoter leads to increased expression in non-small cell lung cancer. Gene Chromosome Cancer 2011;50:830-6.
35. Shiba-Ishii A, Noguchi M. Aberrant stratifin overexpression is regulated by tumor-associated CpG demethylation in lung adenocarcinoma. Am J Pathol 2012;180:1653-62.
36. Kulkarni A, Mehendale S, Pisal H, Kilari A, Dangat K, Salunkhe S, et al. Association of omega-3 fatty acids and homocysteine concentrations in preeclampsia. Clin Nutr 2011;30:60-4.
37. Choudhury M, Friedman JE. Obesity: childhood obesity-methylate now, pay later? Nat Rev Endocrinol 2011;7:439-40.
38. Gao WL, Li D, Xiao ZX, Liao QP, Yang HX, Li YX, et al. Detection of global DNA methylation and paternally imprinted H19 gene methylation in preeclamptic placentas. Hypertens Res 2011;34:655-61.
39. Nomura Y, Lambertini L, Rialdi A, Lee M, Mystal EY, Grabie M, et al. Global methylation in the placenta and umbilical cord blood from pregnancies with maternal gestational diabetes, preeclampsia, and obesity. Reprod Sci 2014;21: 131-7.
40. Hogg K, Blair JD, von Dadelszen P, Robinson WP. Hypomethylation of the LEP gene in placenta and elevated maternal leptin concentration in early onset pre-eclampsia. Mol Cell Endocrinol 2013;367:64-73.
41. Hahn MA, Qiu RX, Wu XW, Li AX, Zhang HY, Wang J, et al. Dynamics of 5-hydroxymethylcytosine and chromatin marks in mammalian neurogenesis. Cell Rep 2013;3:291-300.
42. Kaas GA, Zhong C, Eason DE, Ross DL, Vachhani RV, Ming GL, et al. TET1 controls CNS 5-methylcytosine hydroxylation, active DNA demethylation, gene transcription, and memory formation. Neuron 2013;79:1086-93.
43. Figueroa ME, Abdel-Wahab O, Lu C, Ward PS, Patel J, Shih A, et al. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell 2010;18: 553-67.
44. Hu LL, Li Z, Cheng JD, Rao QH, Gong W, Liu MJ, et al. Crystal structure of TET2-DNA complex: insight into TET-mediated 5mC oxidation. Cell 2013;155: 1545-55.